Vesiculo-erosive oral mucosal disease--management with topical corticosteroids: (2) Protocols, monitoring of effects and adverse reactions, and the future.
Although topical corticosteroids (TCs) are the most widely used drugs in oral medicine, and specifically in the treatment of vesiculo-erosive oral mucosal disease, there are few evidence-based data for the correct use of these drugs. In this review, we outline the most widely used protocols, the most common reasons for treatment failure, and the adverse effects documented in the literature.
González-Moles
M A
MA
Professor of Oral Medicine, Departamento de Medicina Oral, School of Dentistry, Facultad de Odontología, Universidad de Granada, Campus de Cartuja sn, 18071, Granada, Spain. magonzal@ugr.es
Scully
C
C
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002180:Candidiasis, Oral / Q000209:etiology; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D009059:Mouth Diseases / Q000188:drug therapy*; D009061:Mouth Mucosa / Q000187:drug effects; D009067:Mouthwashes / Q000009:adverse effects; D010146:Pain / Q000188:drug therapy; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy*; D017211:Treatment Failure
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009067:Mouthwashes